ArticlePloS one2026

Correction: Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves cisplatin treatment efficacy.

PLOS One StaffPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.